Chronic Stress Reduces Endocannabinoid Signaling in a Depression-Related Brain Region

Chronic unpredictable mild stress reduced CB1 receptor mRNA and protein in the ovBNST, associated with depression-like behaviors. Blocking CB1 in this region induced depression in healthy mice. CB1 agonist or endocannabinoid enhancement partially rescued despair behaviors but not anhedonia in stressed mice.

Preclinical study using CUMS mouse model with endocannabinoid sensors, pharmacological manipulation (CB1 agonist/antagonist), viral tracing, RNAscope, and Western blotting to map endocannabinoid changes in the ovBNST.

This identifies a specific brain region and mechanism through which chronic stress leads to depression via endocannabinoid dysfunction, providing a more precise target for future therapies than broad cannabinoid approaches.

Depression involves many brain circuits, and the endocannabinoid system's role is increasingly clear. This study pinpoints the ovBNST as a critical node where stress disrupts endocannabinoid signaling, potentially explaining why cannabis affects mood.

Mouse CUMS model is a simplified approximation of human depression. Pharmacological interventions rescued only despair, not anhedonia. The specific brain region may not map precisely to human anatomy.